We are live on
!
Find out more
AstraZeneca
AZN
AZN
449 hedge funds and large institutions have $8.63B invested in AstraZeneca in 2016 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 113 increasing their positions, 161 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
177% more call options, than puts
Call options by funds: $211M | Put options by funds: $76.1M
5% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 74
0% more funds holding
Funds holding: 449 → 449 (0)
0.61% less ownership
Funds ownership: 13.09% → 12.48% (-0.61%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
20% less capital invested
Capital invested by funds: $10.8B → $8.63B (-$2.19B)
30% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 161
Holders
449
Holders Change
–
Holders Change %
0%
% of All Funds
11.23%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
78
Increased
113
Reduced
161
Closed
74
Calls
$211M
Puts
$76.1M
Net Calls
+$135M
Net Calls Change
+$30.8M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$262M |
| 2 |
Primecap Management
Pasadena,
California
|
+$246M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$211M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$42M |
| 5 |
Jennison Associates
New York
|
+$40.8M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$451M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
-$148M |
| 3 |
ClearBridge Investments
New York
|
-$131M |
| 4 |
Renaissance Technologies
New York
|
-$122M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$96.1M |